ICLR Long Call Strategy
ICLR (ICON Public Limited Company), in the Healthcare sector, (Medical - Diagnostics & Research industry), listed on NASDAQ.
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations.
ICLR (ICON Public Limited Company) trades in the Healthcare sector, specifically Medical - Diagnostics & Research, with a market capitalization of approximately $13.01B, a trailing P/E of 29.61, a beta of 1.27 versus the broader market, a 52-week range of 66.57-211, average daily share volume of 1.2M, a public-listing history dating back to 1998, approximately 41K full-time employees. These structural characteristics shape how ICLR stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.27 places ICLR roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a long call on ICLR?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
Current ICLR snapshot
As of June 30, 2026, spot at $173.65, ATM IV 40.20%, IV rank 10.39%, expected move 11.53%. The long call on ICLR below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this long call structure on ICLR specifically: ICLR IV at 40.20% is on the cheap side of its 1-year range, which favors premium-buying structures like a ICLR long call, with a market-implied 1-standard-deviation move of approximately 11.53% (roughly $20.01 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ICLR expiries trade a higher absolute premium for lower per-day decay. Position sizing on ICLR should anchor to the underlying notional of $173.65 per share and to the trader's directional view on ICLR stock.
ICLR long call setup
The ICLR long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ICLR near $173.65, the first option leg uses a $175.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ICLR chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ICLR shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $175.00 | $5.30 |
ICLR long call risk and reward
- Net Premium / Debit
- -$530.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$530.00
- Breakeven(s)
- $180.30
- Risk / Reward Ratio
- Unbounded
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
ICLR long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on ICLR. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$530.00 |
| $38.40 | -77.9% | -$530.00 |
| $76.80 | -55.8% | -$530.00 |
| $115.19 | -33.7% | -$530.00 |
| $153.59 | -11.6% | -$530.00 |
| $191.98 | +10.6% | +$1,167.93 |
| $230.37 | +32.7% | +$5,007.32 |
| $268.77 | +54.8% | +$8,846.71 |
| $307.16 | +76.9% | +$12,686.10 |
| $345.55 | +99.0% | +$16,525.48 |
When traders use long call on ICLR
Long calls on ICLR express a bullish thesis with defined risk; traders use them ahead of ICLR catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
ICLR thesis for this long call
The market-implied 1-standard-deviation range for ICLR extends from approximately $153.64 on the downside to $193.66 on the upside. A ICLR long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current ICLR IV rank near 10.39% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on ICLR at 40.20%. As a Healthcare name, ICLR options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ICLR-specific events.
ICLR long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ICLR positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ICLR alongside the broader basket even when ICLR-specific fundamentals are unchanged. Long-premium structures like a long call on ICLR are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current ICLR chain quotes before placing a trade.
Frequently asked questions
- What is a long call on ICLR?
- A long call on ICLR is the long call strategy applied to ICLR (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With ICLR stock trading near $173.65, the strikes shown on this page are snapped to the nearest listed ICLR chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are ICLR long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the ICLR long call priced from the end-of-day chain at a 30-day expiry (ATM IV 40.20%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$530.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a ICLR long call?
- The breakeven for the ICLR long call priced on this page is roughly $180.30 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ICLR market-implied 1-standard-deviation expected move is approximately 11.53%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on ICLR?
- Long calls on ICLR express a bullish thesis with defined risk; traders use them ahead of ICLR catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current ICLR implied volatility affect this long call?
- ICLR ATM IV is at 40.20% with IV rank near 10.39%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.